STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

SOPH insider Form 144 for 3,866 shares on NASDAQ

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SOPH filed a Form 144 notice for a proposed sale of 3,866 common shares. The shares were acquired as restricted stock units on 10/02/2025 and are slated for sale on or about 10/03/2025 through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ. The filing lists an aggregate market value of $17,281.02 for the proposed shares and notes 67,579,560 shares outstanding.

The notice also details recent Rule 10b5-1 sales over the past three months: 09/19/2025 (381 shares; $1,211.35), 08/19/2025 (380; $1,304.01), 07/23/2025 (66; $226.38), 07/21/2025 (381; $1,349.54), and 07/07/2025 (1,703; $5,155.49).

Positive

  • None.

Negative

  • None.

Insights

Administrative Form 144 for a modest planned insider sale.

The filing lists a proposed sale of 3,866 common shares via Morgan Stanley Smith Barney LLC with an $17,281.02 aggregate market value. The shares were acquired as restricted stock units on 10/02/2025, with the approximate sale date on 10/03/2025 and trading on NASDAQ.

The document also itemizes recent Rule 10b5-1 sales over the prior three months with specific amounts and gross proceeds. The issuer’s shares outstanding are disclosed as 67,579,560, which provides scale but does not change the mechanics of this notice.

Form 144 is a notice of proposed sales by affiliates or holders of restricted stock. Actual sales depend on market conditions and applicable Rule 144 limits; the filing itself does not indicate execution timing beyond the stated approximate date.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did SOPH disclose in this Form 144 filing?

A proposed sale of 3,866 common shares with an $17,281.02 aggregate market value, to be sold on or about 10/03/2025 on NASDAQ.

How were the SOPH shares to be sold acquired?

The filing states they were acquired as restricted stock units on 10/02/2025.

Which broker is listed for the SOPH Form 144 sale?

The broker is Morgan Stanley Smith Barney LLC Executive Financial Services, New York.

How many SOPH shares are outstanding according to the notice?

The filing lists 67,579,560 shares outstanding.

What recent SOPH 10b5-1 sales are reported in the filing?

Reported sales include 09/19/2025 (381; $1,211.35), 08/19/2025 (380; $1,304.01), 07/23/2025 (66; $226.38), 07/21/2025 (381; $1,349.54), and 07/07/2025 (1,703; $5,155.49).

On which exchange will the SOPH shares be sold?

The filing identifies NASDAQ as the exchange.

What is the approximate date of the SOPH share sale in the Form 144?

The notice lists 10/03/2025 as the approximate date of sale.
Sophia Genetics Sa

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

334.49M
63.48M
6.46%
48.2%
0.06%
Health Information Services
Healthcare
Link
Switzerland
Rolle